Table 1.

Comparison of Oral Insulin Companies That Will Be Presented in This Review (in Alphabetical Order)

Oral insulin companies	Dose (U)	Total daily dose	Functional bio-availability	Mechanism	Hepatic targeting
Biocon	300–500	1200–2000	Low	Active transport	No
Diabetology	150/300	600–1200	Low	Active transport	No
Diasome	5	20	High	Tight junction	Yes
Emisphere	300	1200	Low	Active transport	No
Oramed	236	944	Low	Active transport	Possible
(modified after Diasome)